Dimensional Fund Advisors
RPRX

Dimensional Fund Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

Dimensional Fund Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-26,466
Closed -$264K – 3558
2014
Q4 		$264K Hold
26,466
– – ﹤0.01% 3218
2014
Q3 		$262K Hold
26,466
– – ﹤0.01% 3239
2014
Q2 		$458K Hold
26,466
– – ﹤0.01% 3203
2014
Q1 		$470K Hold
26,466
– – ﹤0.01% 3207
2013
Q4 		$484K Hold
26,466
– – ﹤0.01% 3176
2013
Q3 		$709K Sell
26,466
-2,066
-7% -$44.3K ﹤0.01% 3112
2013
Q2 		$526K Buy
+28,532
New +$504K ﹤0.01% 3168

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors's RPRX Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of Repros Therapeutics Inc. (RPRX) in Q1 2015, closing a stake of 26,466 shares — an estimated $264K sold.

Dimensional Fund Advisors first reported a position in RPRX in Q2 2013 and held it in 7 quarters. The position peaked at $709K in Q3 2013. 72 funds tracked by Wall St. Rank hold RPRX as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining Repros Therapeutics Inc. position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 26,466 Repros Therapeutics Inc. shares in Q1 2015, an estimated $264K.
  • Dimensional Fund Advisors first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 7 quarters.
  • Dimensional Fund Advisors's Repros Therapeutics Inc. position peaked at $709K in Q3 2013.
  • 72 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.